Nautilus Biotechnology (NAUT) Shares Outstanding (2020 - 2026)

Nautilus Biotechnology has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $127.2 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 0.73% year-over-year to $127.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $127.2 million (up 0.73% YoY) and the FY2025 annual result came in at $126.5 million, changed 0.29% from the prior year.
• Shares Outstanding (Entity) was little changed at $127.2 million in Q2 2026 per NAUT's latest filing, from $127.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $127.2 million in Q2 2026 and troughed at $124.5 million in Q1 2022.
• A 5-year average of $125.6 million and a median of $125.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) jumped 732.49% in 2022, then grew 0.16% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $124.9 million in 2022, then advanced by 0.16% to $125.1 million in 2023, then advanced by 0.83% to $126.1 million in 2024, then advanced by 0.29% to $126.5 million in 2025, then grew by 0.6% to $127.2 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $127.2 million, $127.1 million, and $126.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.